Form 4: BeiGene COO Sells Shares
Insider Transaction (Form 4)
Xiaobin Wu, President and COO of BeiGene, Ltd., sold 280 shares of common stock on August 25, 2026 for $380.00 per share.
Summary
- Open-market sale: disposed of 280 American Depositary Shares at $380.00 ($106,400) on August 25, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $106,400 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Xiaobin Wu — Officer (President and COO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-25 | Open-market sale | American Depositary Shares | 280 | $380 | $106.4K | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-25 | Open-market sale (280 shares) |
Keywords
insider transaction, Form 4, ONC, BeOne Medicines Ltd., bearish, Xiaobin Wu
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.